eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » Draft Guidance for Industry on Enrichment Strategies for Clinical Trials to Support Approval of Human Drugs and Biological Products; Extension of Comment Period

Draft Guidance for Industry on Enrichment Strategies for Clinical Trials to Support Approval of Human Drugs and Biological Products; Extension of Comment Period

Document ID: FDA-2012-D-1145-0005
Document Type: Notice
Agency: Food And Drug Administration
Topics: No Topics associated with this document
Federal Register Number: 2013-02293
View Document:  View as format pdf View as format html

Details Information

Document Subtype: Extension of Comment Period
Received Date: February 04 2013, at 12:00 AM Eastern Standard Time
Start-End Page: 7784 - 7785
Page Count: 2
Comment Start Date: February 4 2013, at 12:00 AM Eastern Standard Time
Comment Due Date: March 18 2013, at 11:59 PM Eastern Standard Time

Comments

    View All
Total: 24
Roche Diagnostics - Comment
Posted: 03/19/2013     ID: FDA-2012-D-1145-0011

Mar 18,2013 11:59 PM ET
Robert A. Beckman - Comment
Posted: 03/19/2013     ID: FDA-2012-D-1145-0006

Mar 18,2013 11:59 PM ET
Living Well Black Inc (LWB) - Comment
Posted: 03/19/2013     ID: FDA-2012-D-1145-0027

Mar 18,2013 11:59 PM ET
AbbVie - Comment
Posted: 03/19/2013     ID: FDA-2012-D-1145-0019

Mar 18,2013 11:59 PM ET
Eli Lilly and Company - Comment
Posted: 03/19/2013     ID: FDA-2012-D-1145-0020

Mar 18,2013 11:59 PM ET

Related Documents

Total: 0
No documents available.